Quick Take: Challenges of vaccine production & distribution

Ian Bremmer's Quick Take:

Hi, everybody. Ian Bremmer here, back in the office in New York City. And I've got my Christmas scarf going, it feels... It's the time of the holidays, get your trees, decorate, right? I usually have a little tree trimming party, which means everybody else comes and trims the tree with me. Not this year, but nonetheless, soon to be, Merry Christmas to everybody and lots to talk about.

I guess, biggest thing on my mind right now is the rollout of these vaccines. I mean, on the one hand it's I know it's challenging the push and pull of the United States right now being in the teeth of the worst of the pandemic in terms of cases, in terms of hospitalizations, and even now in terms of deaths. And that's with mortality rates significantly lower than they were six months ago, but the case level has been so explosive that the death rates are still higher than they were at the earlier peak back in the spring. And given where hospitalizations now are and given where cases are certainly going to be, those numbers are going to keep going up. So, on the one hand we're looking at maybe half a million total dead by the time we get to end of January, February, and the next couple of months are going to be really, really hard.


On the other hand, we are now also looking at people getting vaccinated, we're looking at real solutions. And those solutions come first and foremost to the people that are by far the most vulnerable. Now, usually you would be focused on how quickly can everybody get this vaccine, but I do think it's important because this disease hits so much worse a relatively small piece of the population, the very old and those with serious pre-existing conditions, and particularly when those two groups collide. And those are precisely the people along with first responders and hospitals that are going to be getting the vaccines first.

So, I mean, irrespective of difficulties in rollout, irrespective in fake news around anti-vaxxer sentiment, we're going to see within two months a very, very significant reduction in the mortality rate of this disease, because the people that are most vulnerable are suddenly going to be vaccinated. And they'll only get some immunity immediately, they'll need to get that second course, the booster shot, which gets them up to 95% and that takes a few weeks after the first shot, but still, that's a very positive outcome.

Having said that, in terms of getting the country and getting the world back up and running there is an enormous degree of uncertainty around what happens next year on how quickly we're going to be able to roll out the vaccine. I just saw from Secretary of Health and Human Services, Azar, an expectation that most people in the US are going to be able to be vaccinated by second quarter. I agree that that is possible, it is the best-case scenario, it is absolutely not something you want to do bet on right now, and there are a few reasons for it.

The first is that we have no idea how difficult it is going to be to produce and roll out this vaccine, these vaccines that we're using Pfizer and Moderna. These are the two that everyone in the US will want to take, they're the two that have the highest degree of efficiency. But they're also the two with the very difficult infrastructure requirements, the serious cold chain requirements, in the case of Pfizer, also a need to dilute the vaccine on site before it's given to patients and that requires specialized labor which is already stretched.

So you've got significant infrastructure needs. You're also talking about producing at massive scale vaccines using technologies that have never been produced before. I mean, Pfizer's produced a lot of vaccines, they've been around for a long, long time, they're a big, big pharmaceutical company, global pharmaceutical company, but no one's ever produced an mRNA vaccine before. Moderna has never produced anything before, they've been around for 10 years, this is their first commercial product. So I mean, everything has to go right to get it out there by April.

And when you hear people talking about side effects, some of those are I'm sure going to be exaggerated, some of those side effects we don't necessarily know at scale yet. I spoke with a friend of mine who's on the Coronavirus Task Force for Biden, he took both courses of the Moderna vaccine and after the booster shot, he was out for three days with a heavy fever and wasn't able to go to work. And I can imagine a lot of people thinking they take the first shot, and they say, "Ah, I didn't feel great after that first shot, I don't really need to take the second shot, nevermind." And then suddenly you don't have 95% effective effectiveness, you have 50 or 60% effectiveness and it's a radically different story in terms of getting the vaccines out there. Then there's also huge difference between if 80% of the people say they'll take it, and if only 60% do. And anti-vax sentiment in the United States is reasonably high and there's going to be massive disinformation that's going to be put out in an unprecedented polarization of social media in the United States right now.

I mean, when a majority of Republicans think the election was stolen, how many people are going to think that this vaccine is unsafe or that one of the vaccines is unsafe and then decide they want to take the other one, but it's not available for everybody. I mean, there are a lot of things that can go wrong, can go wrong around information, can go wrong around manufacturing, can go wrong around distribution.

And then you've got the global side of this, which is also really interesting. One of the things we don't know is how long your immunity lasts once you've taken both courses of these vaccines, is it six months to 12 months? Is it 18 months? We have no idea. The United States has ordered an enormous amount of these vaccines, and if we knew that the vaccines were going to last for a year or two years, there would be a significant willingness after the US produces to start exporting a lot of that vaccine to other countries. On the other hand, if you've got problems in your manufacturing, in your distribution and/or if there's real uncertainty around how long your immunity lasts, the United States and other countries are going to want to stockpile a lot more of the vaccine than they otherwise would, which means they're not going to be exporting it to other countries.

You know who will be exporting it to other countries? China. They're doing a lot of producing, their vaccine isn't as good, but it doesn't require the cold chain, just basic refrigeration. And also, they don't need a lot of vaccines for China itself, at least not near term, because they've got massive surveillance capabilities and quarantine capabilities, they can demand that of their population. They'll give it to the frontline workers, but most Chinese people don't necessarily need the vaccine if you've already hammered down the virus, right? I mean, it's like New Zealand, for example. It's like Australia today, for example. Which means China's going to be engaging and exporting all of these vaccines internationally, whether the US can or will is an uncertainty right now, that's a massive difference between those two countries and potentially leads to big, big conflict between the United States and China and the issue that is the most important next year, which is how are we doing on vaccines? It matters to getting our economies restarted, it matters to unemployment, it matters to growth, and it matters to geopolitics.

A lot of uncertainty here, we hope for the best-case scenario, it is a real scenario, it is plausible. I mean, the United States did a good job on the economics in 2020 until very recently, did a lousy job on the healthcare response to coronavirus in terms of masking and PPE and all of the rest. But so far has done a very good job, some of the world's best in terms of vaccine development. Now we have to see for 2021, how the United States is going to do on vaccine production and distribution, and as of right now, we don't know. That level of uncertainty is probably greater than any near-term issue I can imagine that we knew about it, but we just didn't know how well it was going to work, the impact that's going to have on so many factors in the US and globally is just massive, something we'll be paying an enormous attention to and rooting for quite a bit over the coming months.

So that's enough for me for now, hope you guys are well, stay safe and avoid people.

A sector that's rapidly expanding, domotics - domus (home) plus robotics - are smart houses that manage temperature and lighting to minimize wasted electricity. For example, smart thermostats sense your presence and set the temperature according to your needs, saving 20% a year on heating bills. Watch this episode of Eni's Energy Shot series to learn how domotics save money and increase a home's value.

Even if the US, Europe, China, and India reduce carbon emissions at the rate they've promised, much climate damage has already been done. That shouldn't stop these and other countries from doing all they can to meet their net-zero emissions targets, but they also better start preparing for a world of people on the move.

Climate change will displace an unprecedented number of people in coming years, creating not just a series of humanitarian crises in many parts of the world, but lasting political, economic, and social upheaval as those of us who live on higher ground try to find a sustainable place for these climate refugees to live.

More Show less

Listen: In a wide-ranging interview with Ian Bremmer, Pulitzer Prize-winning climate journalist Elizabeth Kolbert assesses the current state of the climate crisis and answers a simple question: how screwed are we? And as the climate continues to warm at a record pace, she unpacks some of the more extreme climate solutions that some increasingly desperate nations are starting to consider. Such measures may sound like stuff of science fiction (see: injecting sulfur particles into the atmosphere or shooting millions of tiny orbital mirrors into outer space) as times become more desperate, their appeal is growing. Can we fix the planet the same way we broke it?

China is making its neighbors nervous these days. Chinese fighter jets are screaming into Taiwan's airspace. Hundreds of armed Chinese "fishing boats" are plying the disputed waters of the South China Sea. And Beijing is slashing imports from some trading partners because of disputes over political issues.

To push back against this increasingly aggressive behavior, regional powers Japan, India, and Australia, together with the US, are boosting cooperation via a 17-year-old grouping called the Quadrilateral Security Dialogue, or simply "The Quad." But how effectively can these four countries really work together to counter China? Eurasia Group's Peter Mumford discusses the Quad's future.

More Show less

Want to tackle climate change? If so you'll have to reach out to China, which is currently responsible for over a quarter of global carbon dioxide emissions. Beijing will certainly take your call, as climate is a huge priority for President Xi Jinping.

Xi has promised that China will go "net zero" — meaning its carbon emissions will be offset by equal amounts of either natural or tech-driven carbon capture — by 2060. Is a decade later than most of the top 10 polluting countries fast enough for the rest of the world? It is for the Chinese, who want to help but have their own ideas about how.

More Show less

When will it be safe for the world's children to be vaccinated against COVID-19? The World Health Organization's chief scientist, Dr. Soumya Swaminathan, says that vaccines are being tested in children down to the age of six or even lower, and promises that data on children will be shared as soon as it's available. She also notes that there are not enough studies on transmission in schools, and the WHO has advised governments to prioritize schools "over other things like shopping malls or cinema halls or pubs." Dr. Swaminathan spoke with Ian Bremmer in an interview on GZERO World, airing on US public television stations starting April 9. Check local listings.

Watch the episode: Vaccine nationalism could prolong the pandemic

Over the past half century, climate change has had an immense impact on the farmers who produce the food we eat. A new study by Cornell University shows that global warming has knocked 21 percent off of global agriculture productivity growth since 1965, equivalent to seven years of normal growth if humans had not polluted the planet. But not all countries have been affected in the same say. Farmers in warmer parts of the world have been hit hard as conditions grow more arid, but sub-polar regions in Canada or Siberia are now actually better for agriculture because they are not as cold as they used to be. Here we take a look at how climate has affected farming productivity growth around the world.

On Tuesday, a major US intelligence report said the top threat to America right now is China. A day later, John Kerry, the Biden administration's "climate czar," got on a plane to... China.

Such is the drama of ties between the world's two largest economies these days.

More Show less

Subscribe to GZERO Media's newsletter, Signal

The GZERO World Podcast with Ian Bremmer. Listen now.

GZEROMEDIA

Subscribe to GZERO Media's newsletter: Signal

Can "the Quad" constrain China?

Viewpoint